SPRY(ARS Pharmaceuticals, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-06-12 | Karas Eric | Chief Commercial Officer | 公开市场卖出 | 25,000 | $10.00 |
| 2026-06-12 | Fitzpatrick Alexander A | Chief Legal Officer | 公开市场卖出 | 3,355 | $10.00 |
| 2025-11-13 | Dorsey Brian | Chief Operating Officer | 公开市场卖出 | 21,828 | $8.71 |
| 2025-11-12 | Chakma Justin | Chief Business Officer | 公开市场卖出 | 136,380 | $8.86 |
| 2025-11-12 | Chakma Justin | Chief Business Officer | 公开市场卖出 | 30,000 | $8.91 |
| 2025-08-21 | Lowenthal Richard E | PRESIDENT AND CEO | 公开市场卖出 | 50,000 | $14.49 |
| 2025-08-21 | Scott Kathleen D. | Chief Financial Officer | 公开市场卖出 | 12,500 | $15.00 |
| 2025-08-20 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | 公开市场卖出 | 37,656 | $14.09 |
| 2025-08-19 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | 公开市场卖出 | 12,344 | $14.03 |
| 2025-07-01 | Karas Eric | Chief Commercial Officer | 公开市场卖出 | 15,000 | $16.99 |
| 2025-06-27 | Flynn James E | 10% 股东 | 公开市场卖出 | 370,074 | $18.46 |
| 2025-06-27 | Flynn James E | 10% 股东 | 公开市场卖出 | 370,075 | $18.46 |
| 2025-06-18 | Karas Eric | Chief Commercial Officer | 公开市场卖出 | 15,000 | $16.00 |
| 2025-05-20 | Fitzpatrick Alexander A | Chief Legal Officer | 公开市场卖出 | 102,969 | $14.10 |
| 2025-05-20 | SAUNDERS BRENT L | 董事 | 公开市场卖出 | 120,000 | $14.25 |
| 2025-05-20 | Scott Kathleen D. | Chief Financial Officer | 公开市场卖出 | 50,000 | $14.10 |
| 2025-04-07 | Shawver Laura | 董事 | 公开市场卖出 | 50,002 | $12.30 |
| 2025-03-20 | Karas Eric | Chief Commercial Officer | 公开市场卖出 | 10,000 | $14.00 |
| 2025-03-06 | Shawver Laura | 董事 | 公开市场卖出 | 49,600 | $11.21 |
| 2025-03-05 | Shawver Laura | 董事 | 公开市场卖出 | 400 | $11.00 |